source
- CREATE Medicines raises $122 million to advance CAR-T candidates into human trialsCREATE Medicines, formerly Myeloid Therapeutics, announced a $122 million financing round. The funding came from Newpath Partners, ARCH Venture Partners, Hatteras Venture Partners and other invest…
- Acting FDA Commissioner Kyle Diamantas Seen as Drama-Free Stabilizer for BiotechKyle Diamantas has been named the acting commissioner of the Food and Drug Administration, stepping into the role after Marty Makary’s resignation. He previously led the FDA’s food safety division,…